Mefatinib

• Description:

  Mefatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1].

• Product Name Alternative:

  Mifanertinib (dimaleate)

• UNSPSC:

  12352005

• Target:

  C-Met/HGFR

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/mefatinib.html

• Purity:

  98.90

• Solubility:

  H2O : 100 mg/mL (ultrasonic)

• Smiles:

  OC(/C=C\C(O)=O)=O.O=C(NC1=CC2=C(NC3=CC=C(C(Cl)=C3)F)N=CN=C2C=C1OC(F)F)/C=C/CN(C)C.OC(/C=C\C(O)=O)=O

• Molecular Formula:

  C29H27ClF3N5O10

• Molecular Weight:

  698.00

• References & Citations:

  [1]WHO Drug Information-World Health Organization (WHO) .

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [1989592-50-8]